Stock Events

Stock Events

HLS Therapeutics (HLS.V) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.25

-0.21

-0.17

-0.13

Details

Expected EPS

-0.1667401696

Actual EPS

-0.194894

Surprise EPS

-0.03

Surprise Percent

+16.88%

Description

HLS Therapeutics (HLS.V) has reported earnings of -0.194894 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.